专利检索_ 链球菌属乳球菌属专利检索_ 链球菌属乳球菌属专利检索查询

子分类：

序号	专利名	申请号	申请日	公开（公告）号	公开（公告）日	发明人
61	Fermented food product and preparation thereof	US458299	1995-06-02	US5645877A	1997-07-08	Walter Gaier
Process for the preparation of a fermented food product for animals, in which a finely divided and emulsified mixture comprising a collagenic material, a protein material and milk is pasteurized while homogenizing constantly, and then it is fermented by lactic acid bacteria. The invention also relates to the product derived from the process.
62	Biologically pure strain of Enterococcus falcium FERM BP-4504	US623007	1996-03-28	US5622859A	1997-04-22	Satoshi Iritani; Masakazu Mitsuhashi; Hiroto Chaen; Toshio Miyake
Disclosed is an alkali-treated bagasse prepared by softening a bagasse with calcium oxide together with or without sodium hydroxide while preventing the substantial decomposition of cellulose and hemicellulose, a bagasse feed and a fermented bagasse feed prepared from the alkali-treated bagasse, and their preparations and uses as well as bacteria for fermenting the alkali-treated bagasse. These bagasse and bagasse feeds save sugar-refinery industries from the difficulties to treat bagasse deemed as an unutilized industrial waste, and livestock farming industries from the shortage of roughage, and further is extremely significant in agriculture, industries of sweetening products, feed industries and livestock product processors. A bacterium strain particularly useful for the fermentation is Enterococcus faecium FERM BP-4504.
63	Probiotic	US300207	1994-09-02	US5589168A	1996-12-31	William D. Allen; Margaret A. Linggood; Philip Porter
A novel strain of Enterococcus faecium, deposited as NCIMB 40371, has valuable probiotic properties and is particularly effective in alleviating symptoms of irritable bowel syndrome in human patients. The novel strain can be used in the manufacture of human foodstuffs.
64	Alkali-treated bagasse, and its preparation and uses	US364489	1994-12-27	US5545418A	1996-08-13	Satoshi Iritani; Masakazu Mitsuhashi; Hiroto Chaen; Toshio Miyake
An alkali-treated bagasse is prepared by softening a bagasse with calcium oxide together with or without sodium hydroxide while preventing the substantial decomposition of cellulose and hemicellulose, a bagasse feed and a fermented bagasse feed prepared from the alkali-treated bagasse, and their preparations and uses as well as bacteria for fermenting the alkali-treated bagasse.
65	Composition and process used for stabilizing egg proteins subjected to subsequent heat treatment	US366072	1994-12-29	US5464639A	1995-11-07	Gene F. Clyde; Marta P. Izquierdo Quimi; Luis R. King Solis
Egg proteins, more specifically egg yolk proteins, or emulsions containing egg yolk proteins which are intended to subsequent thermal treatment, e.g. heat sterilization, are stabilized by addition thereto of an acidic amylaceous fermented composition resulting from a process whereina) a slurry of cereal flour and at least one additional non-cereal starch material is first subjected to gelatinization and further homogenized;b) inoculated with an acidifying strain or a mixture of acidifying strains selected from Lactobacillus species and Streptococcus thermophilus;c) then subjected to a fermentation over a period and at a temperature such as to afford a pH of about 4.0 to 4.2 of the fermented material; andd) finally stabilized.Stabilizing composition useful therefor and foodstuffs containing same.
66	Method of reducing the health risks during the handling of packaged non-sterilized foodstuffs	US78114	1987-07-27	US4894243A	1990-01-16	Lennart Ahrne
In order to prevent health risks which may occur if packaged, non-sterilized foodstuffs such as milk and similar sensitive dairy products are subjected during transport, storage etc. prior to consumption to accidental bacteria-promoting conditions, e.g. temperatures above the highest recommended temperature, innocuous bacteria are added to the foodstuffs before and/or directly following their packaging in a quantity sufficient to compete out, and thereby eliminate the risk of multiplication dangerous to health of, harmful, in particular pathogenic, bacteria in the packaged product.
67	Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same	US14755550	2015-06-30	US09951360B2	2018-04-24	Yoshikazu Isono; Hisako Mori; Tomomi Ueno; Rieko Endo; Megumi Kumemura; Yasuhiro Abiru; Shigeto Uchiyama
An object of the present invention is to provide a fermented product containing equol-producing microorganisms in the state of living cells by which equol production ability is maintained.When producing a fermented material by using an equol-producing microorganism, with soybean powder or soybean milk as raw materials, (1) preparing a mother starter by fermentation under anaerobic conditions by using an equol-producing microorganism in the presence of a daidzein species at pH 5.0 or higher, (2) preparing a bulk starter by fermentation under anaerobic conditions by using said mother starter in the presence of a daidzein species at pH 5.0 or higher, and (3) preparing a fermented material by fermentation by using said bulk starter in a medium containing soybean powder or soybean milk, enables production of a fermented material containing microorganisms in the state of living cells in which the equol production ability is maintained.
68	Butyrogenic bacteria as probiotics to treat clostridium difficile	US14773432	2014-03-09	US09669059B2	2017-06-06	Gary P. Wang
The subject invention pertains to the use of certain bacterial strains, particularly butyrogenic bacteria, for preparing a composition to treat and/or prevent Clostridium difficile infection. In particular, the invention relates to the use of butyrate-producing anaerobic fermenters of gut commensals in pharmaceutical or food compositions.
69	Fermented infant formula with non digestible oligosaccharides	US14407907	2013-06-14	US09617327B2	2017-04-11	Thomas Ludwig; Sylvie Huybers; Evan Abrahamse; Houkje Bouritius
The present invention relates to a fermented infant formulae comprising non digestible oligosaccharides for improving intestinal tract health by decreasing protein digestive effort, by decreasing the amount of endogenously formed proteases concomitant with an increased protein digestion, and a reduced protein fermentation.
70	Use of caftaric acid and lactic bacterium in food supplement for regulating skin pigmentation	US13805887	2011-06-28	US09492416B2	2016-11-15	Marjorie Guitard; Rachid Bel Rhlid; Angus Moodycliffe; Fabiola Dionisi
The present invention relates generally to the field of cosmetic and/or food supplement. More specifically, the present invention aims to provide the use of at least an ingredient containing caftaric acid and/or derivatives and a micro-organism and/or an enzyme capable of hydrolyzing caftaric acid and/or derivatives thereof to generate tartaric and/or caffeic acid, for improving skin tone and preventing and/or treating hyper-pigmentation of skin and/or skin color imperfections such as age-spots and other skin disorders characterized by abnormal pigments. Also, the present invention aims at providing a skin lightening agent.
71	Compositions comprising dehydrated micro-organisms, method for preparing same, and uses thereof	US11815703	2006-02-06	US09259448B2	2016-02-16	Guy Derrieu
The invention relates to a composition comprising revivable dehydrated micro-organisms. The invention is characterized in that it further comprises particles at least 50% of which have a mean diameter greater than 250 μm. The invention is applicable, in particular, to human or veterinary pharmaceuticals, to dietetics or to food products.
72	Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same	US13119353	2009-09-18	US09101159B2	2015-08-11	Yoshikazu Isono; Hisako Mori; Tomomi Ueno; Rieko Endo; Megumi Kumemura; Yasuhiro Abiru; Shigeto Uchiyama
An object of the present invention is to provide a fermented product containing equol-producing microorganisms in the state of living cells by which equol production ability is maintained.When producing a fermented material by using an equol-producing microorganism, with soybean powder or soybean milk as raw materials, (1) preparing a mother starter by fermentation under anaerobic conditions by using an equol-producing microorganism in the presence of a daidzein species at pH 5.0 or higher, (2) preparing a bulk starter by fermentation under anaerobic conditions by using said mother starter in the presence of a daidzein species at pH 5.0 or higher, and (3) preparing a fermented material by fermentation by using said bulk starter in a medium containing soybean powder or soybean milk, enables production of a fermented material containing microorganisms in the state of living cells in which the equol production ability is maintained.
73	FERMENTED INFANT FORMULA WITH NON DIGESTIBLE OLIGOSACCHARIDES	US14407907	2013-06-14	US20150132365A1	2015-05-14	Thomas Ludwig; Sylvie Huybers; Evan Abrahamse; Houkje Bouritius
The present invention relates to a fermented infant formulae comprising non digestible oligosaccharides for improving intestinal tract health by decreasing protein digestive effort, by decreasing the amount of endogenously formed proteases concomitant with an increased protein digestion, and a reduced protein fermentation.
74	Compositions Comprising Dehydrated Micro-Organisms, Method for Preparing Same, and Uses Thereof	US11815703	2006-02-06	US20110014278A1	2011-01-20	Guy Derrieu
The invention relates to a composition comprising revivable dehydrated micro-organisms. The invention is characterised in that it further comprises particles at least 50% of which have a mean diameter greater than 250 μm. The invention is applicable, in particular, to human or veterinary pharmaceuticals, to dietetics or to food products.
75	Refrigerated Dough with Enhanced Microbiological Safety	US11615457	2006-12-22	US20080152758A1	2008-06-26	Zuoxing Zheng; Julia L. DesRochers; Uraiwan Tangprasertchai
The invention is directed to an antimicrobial broth composition, which may be incorporated into a dough or dough-based product to impart enhanced microbiological safety. The invention further discloses a method of preparing a cultured glucose-yeast extract broth and a method of incorporating same into a refrigerated dough formula to enhance its microbiological safety.
76	Method for making fermented food and fermented food made thereby having suppressive effect against helicobactor-pylori and food-poisoning bacillus	US10496603	2002-12-20	US20050008733A1	2005-01-13	Hee-kyong Bae; Jong-wook Son; Jin-hee Lee; Jae-kag Lim
The present invention related to a method for preparing fermented food having suppressive effect against Helicobactor-pylori and food-poisoning bacillus that comprises the steps of inoculating lactic ferments into the food, wherein said lactic ferments is selected from the group consisting of Lactobacillus genus, Bifidobacterium genus, Streptococus genus and the mixture thereof, and said food is selected from the group consisting of grain, fruit, vegetables and their mixture; and incubating said inoculated mixture at 15-35° C. for 12˜48 hours.
77	Metabolically engineered lactic acid bacteria and their use	US08981098	1997-12-17	US06645754B1	2003-11-11	Dan Nilsson
Mutants of lactic acid bacteria including Lactococcus lactis which are defective in pyruvate formate-lyase production and/or in their lactate dehydrogenase (Ldh) production and methods of isolating such mutants or variants are provided. The mutants are useful in the production of food products or in the manufacturing of compounds such as diacetyl, acetoin and acetaldehyde and as components of food starter cultures. In particular, Lactococcus lactis DN223 deposited under the accession No. DSM 11036.
78	Fermented food product for animals	US818782	1997-03-11	US5759598A	1998-06-02	Walter Gaier
A fermented food product is prepared by preparing an aqueous emulsion of milk solids, particulate protein material, particulate collagenic material and water, simultaneously homogenizing and pasteurizing the aqueous emulsion so that collagen is extracted from the collagenic material for thickening the aqueous emulsion, inoculating the thickened pasteurized emulsion obtained with lactic acid bacteria and then incubating the inoculated composition to obtain the fermented product.
79	Priobiotic containing enterococcus faecium strain NCIMB 40371	US697893	1996-09-03	US5728380A	1998-03-17	William Dennis Allen; Margaret Anneli Linggood; Philip Porter
A strain of Enterococcus faecium, deposited as NCIMB 40371, has valuable probiotic properties and is particularly effective in alleviating symptoms of irritable bowel syndrome (IBS) in human patients. The strain can be used in the manufacture of human foodstuffs.
80	Oral nutritional and dietary composition	US239701	1994-05-09	US5501857A	1996-03-26	William A. Zimmer
An oral nutritional supplement, i.e., a dietary adjunct, for livestock which includes incompatible live microbial cultures, and vitamin and mineral supplements, each separated from the other via multiple encapsulation. The microbial cultures include gastrointestinal bacteria, yeasts or fungi. A method of delivering incompatible compounds in vivo, a method of preparing shelf-stable compositions of incompatible substances, and a system for delivering oral nutritional supplements to livestock are also provided.

1 2 3 4 5 6 7 8 9

该功能需要专业版企业版VIP权限，您可以：